36637427|t|Slingshot homolog-1 amplifies mitochondrial abnormalities by distinctly impairing health and clearance of mitochondria.
36637427|a|Accumulating toxic protein assemblies, including Abeta and tau, and dysfunctional mitochondria are associated with synaptic and neuronal loss in Alzheimer's disease (ad). Such accumulations are thought to be due to clearance defects in the autophagy-lysosome pathway. Mitochondrial dysfunction is evident in ad brains and animal models at multiple levels, such as mitochondrial genomic mutations, disrupted bioenergetics, deregulated mitochondrial dynamics, and impaired clearance of damaged mitochondria (mitophagy). Slingshot Homolog-1 (SSH1) is a phosphatase activated by oxidative stress, high intracellular levels of Ca+2, and Abeta42 oligomers (Abeta42O), known for its function to dephosphorylate/activate cofilin through the N-terminal region. SSH1-mediated cofilin dephosphorylation results in Ab42O-induced severing of F-actin and translocation of cofilin to mitochondria, which promotes mitochondria-mediated apoptosis, synaptic loss, and synaptic deficits. On the other hand, SSH1-mediated dephosphorylation/deactivation of the autophagy-cargo receptor p62 (SQSTM1), through its C-terminal region, inhibits p62 autophagy flux. However, the interplay between these two different activities of SSH1 in Abeta42O-induced mitochondrial toxicity remains unclear. In this study, we assessed the role of endogenous SSH1 and different regions of SSH1 in regulating mitochondrial health, mitochondrial respiration, clearance of damaged mitochondria, and synaptic integrity in vitro and in vivo. Our results indicate that SSH1 suppresses mitochondrial health and respiration through the cofilin-binding N-terminal region, whereas SSH1 impairs mitophagy through a newly identified ~ 100 residue p62-binding domain in the C-terminal region. These results indicate that both N-terminal and C-terminal regions negatively impact mitochondria by distinct and independent modalities to amplify mitochondrial abnormalities, making SSH1 an excellent target to mitigate ad pathogenesis.
36637427	0	19	Slingshot homolog-1	Gene	54434
36637427	30	57	mitochondrial abnormalities	Disease	MESH:D028361
36637427	169	174	Abeta	Gene	351
36637427	179	182	tau	Gene	4137
36637427	235	261	synaptic and neuronal loss	Disease	MESH:D012183
36637427	265	284	Alzheimer's disease	Disease	MESH:D000544
36637427	286	288	ad	Disease	MESH:D000544
36637427	388	413	Mitochondrial dysfunction	Disease	MESH:D028361
36637427	428	430	ad	Disease	MESH:D000544
36637427	638	657	Slingshot Homolog-1	Gene	54434
36637427	659	663	SSH1	Gene	54434
36637427	742	746	Ca+2	Chemical	-
36637427	752	759	Abeta42	Gene	351
36637427	833	840	cofilin	Gene	1072
36637427	872	876	SSH1	Gene	54434
36637427	886	893	cofilin	Gene	1072
36637427	923	928	Ab42O	Chemical	-
36637427	978	985	cofilin	Gene	1072
36637427	1051	1064	synaptic loss	Disease	MESH:D012183
36637427	1070	1087	synaptic deficits	Disease	MESH:D009461
36637427	1108	1112	SSH1	Gene	54434
36637427	1185	1188	p62	Gene	8878
36637427	1190	1196	SQSTM1	Gene	8878
36637427	1239	1242	p62	Gene	8878
36637427	1324	1328	SSH1	Gene	54434
36637427	1349	1371	mitochondrial toxicity	Disease	MESH:D028361
36637427	1439	1443	SSH1	Gene	54434
36637427	1469	1473	SSH1	Gene	54434
36637427	1643	1647	SSH1	Gene	54434
36637427	1708	1715	cofilin	Gene	1072
36637427	1751	1755	SSH1	Gene	54434
36637427	1815	1818	p62	Gene	8878
36637427	2008	2035	mitochondrial abnormalities	Disease	MESH:D028361
36637427	2044	2048	SSH1	Gene	54434
36637427	2081	2083	ad	Disease	MESH:D000544
36637427	Association	MESH:D012183	1072
36637427	Association	MESH:D009461	54434
36637427	Association	MESH:D000544	4137
36637427	Positive_Correlation	351	54434
36637427	Association	MESH:D000544	351
36637427	Association	MESH:D012183	54434
36637427	Negative_Correlation	54434	8878
36637427	Positive_Correlation	MESH:D012183	351
36637427	Association	MESH:D028361	54434
36637427	Association	MESH:D009461	1072
36637427	Association	1072	54434
36637427	Association	MESH:D012183	4137

